Clinical Trials: Infectious Disease
Skip
Remdesivir (RDV; GS-5734) for the Treatment of Selected Coronavirus (CoV) Infection, Single Patient Protocol
Study Type/Phase: Emergency Investigational New Drug
Status: Not Recruiting
An experimental treatment called Remdesivir was provided on a compassionate-use basis to patients hospitalized with COVID-19, an illness caused by infection with SARS-CoV-2...
First-In-Human Study To Evaluate Safety, Tolerability, And Pharmacokinetics of PF-07304814 In Hospitalized Participants With COV
Study Type/Phase: 1b
Status: Recruiting
The purpose of this study is to evaluate the safety, effectiveness, and dosing of an investigational drug called PF-07304814 for SARS-CoV-2 infection. This is a Phase 1 trial that...
A Phase 3 Randomized Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734™) in Participants with Moderate COVID-19 Compared to Standard of Care Treatment (GS-US-540-5774)
Study Type/Phase: Phase 3
Status: Not Recruiting
The purpose of this study is to evaluate the safety and effectiveness of an investigational drug called Remdesivir (RDV) for COVID-19. There are no approved medications to treat COVID-19...
A Phase 3 Randomized Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734™) in Participants with Severe COVID-19 (GS-US-540-5773)
Study Type/Phase: Phase 3
Status: Not Recruiting
The purpose of this study is to evaluate the safety and effectiveness of an investigational drug called Remdesivir (RDV) for COVID-19. There are no approved medications to treat COVID-19...